Samlyn Capital’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-370,842
Closed -$2.97M 131
2022
Q1
$2.97M Sell
370,842
-10,228
-3% -$90.2K 0.04% 99
2021
Q4
$4.44M Buy
381,070
+3,815
+1% +$45.7K 0.06% 107
2021
Q3
$4.67M Buy
377,255
+18,495
+5% +$209K 0.06% 110
2021
Q2
$4.4M Buy
+358,760
New +$4.4M 0.06% 97

Other funds holding SLGC

Samlyn Capital's SLGC Position: Q2 2022 in Review

Samlyn Capital sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2022, closing a stake of 370,842 shares — an estimated $2.97M sold.

Samlyn Capital first reported a position in SLGC in Q2 2021 and held it in 4 quarters. The position peaked at $4.67M in Q3 2021. 135 funds tracked by Wall St. Rank hold SLGC as of Q2 2022.

  • Samlyn Capital reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Samlyn Capital sold 370,842 SomaLogic, Inc. Class A Common Stock shares in Q2 2022, an estimated $2.97M.
  • Samlyn Capital first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2021 and held it in 4 quarters.
  • Samlyn Capital's SomaLogic, Inc. Class A Common Stock position peaked at $4.67M in Q3 2021.
  • 135 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2022.

Based on Samlyn Capital's 13F filing for Q2 2022, filed 15 Aug 2022.